ONC Certified EHR

Complete EHR, ONC Certified HIT, 2014

Transparency and Disclosure Statement

This Complete EHR is ONC 2014 Edition compliant and has been certified by ICSA Labs, an ONC-ACB, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Click here to view the certification.

  • Vendor: AntWorks
  • Certified on: March 28, 2014
  • Product Certified: Benchmark Clinical Version 7
  • Certification Number: CC-2014-697871-1

Certified Criteria

Criterion # and Description Met/Exempt
§ 170.314(a)(1) Computerized Provider Order Entry Pass
§ 170.314(a)(2) Drug-Drug, Drug-Allergy Interaction Checks Pass
§ 170.314(a)(3) Demographics Pass
§ 170.314(a)(4) Vital Signs, Body Mass Index, and Growth Charts Pass
§ 170.314(a)(5) Problem List Pass
§ 170.314(a)(6) Medication List Pass
§ 170.314(a)(7) Medication Allergy List Pass
§ 170.314(a)(8) Clinical Decision Support Pass
§ 170.314(a)(9) Electronic Notes Pass
§ 170.314(a)(10) Drug Formulary Checks Pass
§ 170.314(a)(11) Smoking Status Pass
§ 170.314(a)(12) Image Results Pass
§ 170.314(a)(13) Family Health History Pass
§ 170.314(a)(14) Patient List Creation Pass
§ 170.314(a)(15) Patient-Specific Education Resources Pass
§ 170.314(b)(1) Transitions of Care – Receive, Display, and Incorporate Transition Pass
§ 170.314(b)(2) Transitions of Care – Create and Transmit Summary Care Pass
§ 170.314(b)(3) Electronic Prescribing Pass
§ 170.314(b)(4) Clinical Information Reconciliation Pass
§ 170.314(b)(5) Incorporate Laboratory Tests and Values/Results Pass
§ 170.314(b)(7) Data Portability Pass
§ 170.314(c)(1) Clinical Quality Measures – Capture and Export Pass
§ 170.314(c)(2) Clinical Quality Measures – Incorporate and Calculate Pass
§ 170.314(c)(3) Clinical Quality Measures – Electronic Submission Pass
§ 170.314(d)(1) Authentication, Access Control, and Authorization Pass
§ 170.314(d)(2) Auditable Events and Tamper-Resistance Pass
§ 170.314(d)(3) Audit Report(s) Pass
§ 170.314(d)(4) Amendments Pass
§ 170.314(d)(5) Automatic Log-Off Pass
§ 170.314(d)(6) Emergency Access Pass
§ 170.314(d)(7) End-User Device Encryption Pass
§ 170.314(d)(8) Integrity Pass
§ 170.314(d)(9) Optional – Accounting of Disclosures N/A
§ 170.314(e)(1) View, Download, and Transmit to 3rd Party Pass
§ 170.314(e)(2) Clinical Summary – Ambulatory Setting Only Pass
§ 170.314(e)(3) Secure Messaging – Ambulatory Setting Only Pass
§ 170.314(f)(1) Immunization Information Pass
§ 170.314(f)(2) Transmission to Immunization Registries Pass
§ 170.314(f)(3) Transmission to Public Health Agencies – Syndromic Surveillance Pass
§ 170.314(f)(5) Cancer Case Information – Ambulatory Setting Only N/A
§ 170.314(f)(6) Transmission to Cancer Registries – Ambulatory Setting Only N/A
§ 170.314(g)(1) Automated Numerator Recording N/A
§ 170.314(g)(2) Automated Measure Calculation Pass
§ 170.314(g)(3) Safety-Enhanced Design Pass
§ 170.314(g)(4) Quality Management System Pass

 

Clinial Quality Measures

CMS69 PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL
CMS123 DIABETES: FOOT EXAM
CMS124 CERVICAL CANCER SCREENING
CMS125 BREAST CANCER SCREENING
CMS126 USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
CMS130 COLORECTAL CANCER SCREENING
CMS131 DIABETES: EYE EXAM
CMS134 DIABETES: URINE PROTEIN SCREENING
CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION
CMS139 SCREENING FOR FUTURE FALL RISK
CMS142 DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE
CMS143 PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION
CMS144 HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION
CMS148 HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
CMS154 APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
CMS155 WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
CMS156 USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC
CMS165 CONTROLLING HIGH BLOOD PRESSURE
CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN
CMS182 ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL

Self-attested Additional Software Used in Testing

Product Name Product Version Supplier Criteria this product supports
MedKnowledge Oct-16 First Databank Drug Database 170.314(a)(1), 170.314(a)(2), 170.314(a)(6), 170.314(a)(7), 170.314(a)(10), 170.314(b)(1), 170.314(b)(2), 170.314(b)(3), 170.314(b)(7), 170.314(c)(1), 170.314(e)(1), 170.314(e)(2)
Medline Plus NA National Institute of Health 170.314(a)(8), 170.314(a)(15)
Problem (IT) Terminology 2014 R1.1 Intelligent Medical Objects 170.314(a)(1), 170.314(a)(5), 170.314(a)(8), 170.314(a)(11), 170.314(a)(13), 170.314(a)(15), 170.314(b)(1), 170.314(b)(2), 170.314(b)(5), 170.314(b)(7), 170.314(c)(1), 170.314(e)(1), 170.314(e)(2)
Procedure (IT) Terminology 2014 Procedure IT FULL Intelligent Medical Objects 170.314(a)(1), 170.314(a)(8), 170.314(a)(15), 170.314(b)(1), 170.314(b)(2), 170.314(b)(5), 170.314(b)(7), 170.314(c)(1), 170.314(e)(1), 170.314(e)(2)

Disclosure of Additional types of costs

Eligible Providers, Hospitals, or Critical Access Hospitals may be required to pay costs from the list below to implement the Complete EHR’s capabilities in order to attempt to meet meaningful use objectives and measures. These costs include:

  • Monthly Service Fees
  • Interface Development Fees
  • Configuration Fees
  • Integration Fees
  • Third Party Database Products

Disclosure of any limitations

  • None

 

For more information on Benchmark’s ONC Certified EHR, or to learn more specifically about our ONC Certification, please contact us at 1-800-779-0902.